Towards the tumor microenvironment scoring methods for immune checkpoint inhibitor response

Area of Science:

• Oncology
• Immunotherapy
• Computational Biology

Background:

• Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but suffer from low response rates.
• Robust prediction of patient response to ICIs is critical for effective cancer therapy.

Purpose of the Study:

• To evaluate gene-based methods for predicting tumor microenvironment (TME) scores.
• To assess the performance of these scores in predicting survival and ICI response across diverse cancer types.

Main Methods:

• Analysis of gene expression data to derive TME scores.
• Comparison of different scoring methods for predictive accuracy.
• Validation across multiple cancer types, including Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, and Urothelial Cancer.

Main Results:

• The TIP Hot method demonstrated robust predictive performance for ICI response in specific cancers.
• No single gene-based score was universally applicable across all evaluated cancer types.
• Significant variability in tumor biology and host immune responses impacts predictive accuracy.

Conclusions:

• Gene-based TME scores offer potential for predicting ICI response, but current methods lack universal applicability.
• Further research is needed to refine predictive models using larger, diverse datasets and advanced computational techniques.
• Enhanced predictive accuracy is essential for advancing personalized cancer treatment strategies.